TY - JOUR
T1 - Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study
AU - Buwenge, Milly
AU - Cilla, Savino
AU - Guido, Alessandra
AU - Giaccherini, Lucia
AU - Macchia, Gabriella
AU - Deodato, Francesco
AU - Cammelli, Silvia
AU - Cellini, Francesco
AU - Mattiucci, Gian Carlo
AU - Valentini, Vincenzo
AU - Stock, Markus
AU - Morganti, Alessio G.
AU - Morganti, Alessio Giuseppe
PY - 2016
Y1 - 2016
N2 - Aim Aim of this study was to perform a planning feasibility analysis of a 3-level dose prescription using an IMRT-SIB technique. Background Radiation therapy of locally advanced pancreatic cancer should administer a minimum dose to the duodenum and a very high dose to the vascular infiltration areas to improve the possibility of a radical resection. Materials and methods Fifteen patients with pancreatic head adenocarcinoma and vascular involvement were included. The duodenal PTV (PTVd) was defined as the GTV overlapping the duodenal PRV. Vascular CTV (CTVv) was defined as the surface of contact or infiltration between the tumor and vessel plus a 5 mm margin. Vascular PTV (PTVv) was considered as the CTVv plus an anisotropic margin. The tumor PTV (PTVt) was defined as the GTV plus a margin including the PTVv and excluding the PTVd. The following doses were prescribed: 30 Gy (6 Gy/fraction) to PTVd, 37.5 Gy (7.5 Gy/fraction) to PTVt, and 45 Gy (9 Gy/fraction) to PTVv, respectively. Treatment was planned with an IMRT technique. Results The primary end-point (PTVv Dmean > 90%) was achieved in all patients. PTVv D98% > 90% was achieved in 6 patients (40%). OARs constraints were achieved in all patients. Conclusions Although the PTVv D95% > 95% objective was achieved only in 40% of patients, the study showed that in 100% of patients it was possible to administer a strongly differentiated mean/median dose. Prospective trials based on clinical application of this strategy seem to be justified in selected patients without overlap between PTVd and PTVv.
AB - Aim Aim of this study was to perform a planning feasibility analysis of a 3-level dose prescription using an IMRT-SIB technique. Background Radiation therapy of locally advanced pancreatic cancer should administer a minimum dose to the duodenum and a very high dose to the vascular infiltration areas to improve the possibility of a radical resection. Materials and methods Fifteen patients with pancreatic head adenocarcinoma and vascular involvement were included. The duodenal PTV (PTVd) was defined as the GTV overlapping the duodenal PRV. Vascular CTV (CTVv) was defined as the surface of contact or infiltration between the tumor and vessel plus a 5 mm margin. Vascular PTV (PTVv) was considered as the CTVv plus an anisotropic margin. The tumor PTV (PTVt) was defined as the GTV plus a margin including the PTVv and excluding the PTVd. The following doses were prescribed: 30 Gy (6 Gy/fraction) to PTVd, 37.5 Gy (7.5 Gy/fraction) to PTVt, and 45 Gy (9 Gy/fraction) to PTVv, respectively. Treatment was planned with an IMRT technique. Results The primary end-point (PTVv Dmean > 90%) was achieved in all patients. PTVv D98% > 90% was achieved in 6 patients (40%). OARs constraints were achieved in all patients. Conclusions Although the PTVv D95% > 95% objective was achieved only in 40% of patients, the study showed that in 100% of patients it was possible to administer a strongly differentiated mean/median dose. Prospective trials based on clinical application of this strategy seem to be justified in selected patients without overlap between PTVd and PTVv.
KW - IMRT
KW - Oncology
KW - Pancreatic neoplasms
KW - Radiology, Nuclear Medicine and Imaging
KW - Simultaneous integrated boost
KW - Stereotactic body radiotherapy
KW - IMRT
KW - Oncology
KW - Pancreatic neoplasms
KW - Radiology, Nuclear Medicine and Imaging
KW - Simultaneous integrated boost
KW - Stereotactic body radiotherapy
UR - http://hdl.handle.net/10807/92425
UR - http://www.elsevier.com/wps/find/journaldescription.cws_home/719699/description#description
U2 - 10.1016/j.rpor.2016.09.003
DO - 10.1016/j.rpor.2016.09.003
M3 - Article
SN - 1507-1367
VL - 21
SP - 548
EP - 554
JO - Reports of Practical Oncology and Radiotherapy
JF - Reports of Practical Oncology and Radiotherapy
ER -